{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:03:11Z","timestamp":1784264591780,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114427","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T13:10:17Z","timestamp":1741439417000},"page":"114427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Lysozyme modulates inflammatory responses to exacerbate the severity of rheumatoid arthritis"],"prefix":"10.1016","volume":"152","author":[{"given":"Hao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enshui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.intimp.2025.114427_bb0005","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.intimp.2025.114427_bb0010","first-page":"591","article-title":"Global epidemiology of rheumatoid arthritis","volume":"18","author":"Finckh","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/art.40061","article-title":"Editorial: prevention of rheumatoid arthritis: now is the time, but how to proceed?","volume":"69","author":"Deane","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114427_bb0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/annrheumdis-2016-210713","article-title":"Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"76","author":"Nam","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114427_bb0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/annrheumdis-2013-204020","article-title":"Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010","volume":"74","author":"Aga","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2025.114427_bb0030","first-page":"1681","article-title":"Work disability in rheumatoid arthritis 10 years after the diagnosis","volume":"26","author":"Sokka","year":"1999","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114427_bb0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2007.071415","article-title":"Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results","volume":"67","author":"Aletaha","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114427_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/msc.171","article-title":"Psychological well-being in rheumatoid arthritis: a review of the literature","volume":"8","author":"Gettings","year":"2010","journal-title":"Musculoskeletal Care"},{"issue":"1","key":"10.1016\/j.intimp.2025.114427_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2018-000870","article-title":"Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives","volume":"5","author":"Burgers","year":"2019","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.intimp.2025.114427_bb0050","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.intimp.2025.114427_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.bor.0000218950.27483.80","article-title":"Early rheumatoid arthritis","volume":"18","author":"Machold","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"issue":"27\u201328","key":"10.1016\/j.intimp.2025.114427_bb0060","first-page":"477","article-title":"Rheumatoid arthritis--early diagnosis and disease management","volume":"110","author":"Schneider","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"issue":"2","key":"10.1016\/j.intimp.2025.114427_bb0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/1523-1747.ep12349624","article-title":"Isolation and characterization of human skin lysozyme","volume":"57","author":"Ogawa","year":"1971","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2025.114427_bb0070","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI115407","article-title":"Killing of gram-negative bacteria by lactoferrin and lysozyme","volume":"88","author":"Ellison","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.intimp.2025.114427_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006512","article-title":"From bacterial killing to immune modulation: recent insights into the functions of lysozyme","volume":"13","author":"Ragland","year":"2017","journal-title":"PLoS Pathog."},{"issue":"11","key":"10.1016\/j.intimp.2025.114427_bb0080","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1080\/15548627.2022.2039991","article-title":"The Crohn disease-associated ATG16L1(T300A) polymorphism regulates inflammatory responses by modulating TLR- and NLR-mediated signaling","volume":"18","author":"Gao","year":"2022","journal-title":"Autophagy"},{"issue":"9","key":"10.1016\/j.intimp.2025.114427_bb0085","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI107035","article-title":"Human cartilage lysozyme","volume":"51","author":"Greenwald","year":"1972","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.intimp.2025.114427_bb0090","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/art.1780200115","article-title":"Lactoferrin and lysozyme levels in synovial fluid: differential indices of articular inflammation and degradation","volume":"20","author":"Bennett","year":"1977","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.intimp.2025.114427_bb0095","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/ard.48.11.912","article-title":"Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation","volume":"48","author":"Konttinen","year":"1989","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0100","first-page":"853","article-title":"Fine structure and cytochemistry of the rheumatoid synovial membrane, with special reference to lysosomes","volume":"44","author":"Barland","year":"1964","journal-title":"Am. J. Pathol."},{"issue":"12","key":"10.1016\/j.intimp.2025.114427_bb0105","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1093\/rheumatology\/38.12.1249","article-title":"Serum lysozyme: a potential marker of monocyte\/macrophage activity in rheumatoid arthritis","volume":"38","author":"Torsteinsd\u00f3ttir","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2025.114427_bb0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fimmu.2020.00427","article-title":"Heightened levels of antimicrobial response factors in patients with rheumatoid arthritis","volume":"11","author":"Ayyappan","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2025.114427_bb0115","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/1756-185X.13063","article-title":"Identifying key genes in rheumatoid arthritis by weighted gene co-expression network analysis","volume":"20","author":"Ma","year":"2017","journal-title":"Int. J. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0120","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat. Protoc."},{"issue":"12","key":"10.1016\/j.intimp.2025.114427_bb0125","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/annrheumdis-2019-215473","article-title":"CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis","volume":"78","author":"Song","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"18","key":"10.1016\/j.intimp.2025.114427_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135935","article-title":"Increased SUMO-activating enzyme SAE1\/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0135","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrrheum.2015.8","article-title":"Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges","volume":"11","author":"Smolen","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/art.40062","article-title":"Brief report: clinical trials aiming to prevent rheumatoid arthritis cannot detect prevention without adequate risk stratification: a trial of methotrexate versus placebo in undifferentiated arthritis as an example","volume":"69","author":"Burgers","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114427_bb0145","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cvsm.2022.01.009","article-title":"Glucocorticoids, cyclosporine, azathioprine, Chlorambucil, and mycophenolate in dogs and cats: clinical uses, pharmacology, and side effects","volume":"52","author":"Viviano","year":"2022","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"issue":"3","key":"10.1016\/j.intimp.2025.114427_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002817","article-title":"Rheumatoid factor isotypes in rheumatoid arthritis diagnosis and prognosis: a systematic review and meta-analysis","volume":"9","author":"Motta","year":"2023","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.intimp.2025.114427_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10408363.2020.1775545","article-title":"Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis","volume":"58","author":"Savvateeva","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"10416","key":"10.1016\/j.intimp.2025.114427_bb0160","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.intimp.2025.114427_bb0165","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","article-title":"Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985-2014","volume":"79","author":"Myasoedova","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.114427_bb0170","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","article-title":"Immunopathogenesis of rheumatoid arthritis","volume":"46","author":"Firestein","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2025.114427_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00365519409088578","article-title":"The monitoring of inflammation by specific cellular markers","volume":"219","author":"Venge","year":"1994","journal-title":"Scand. J. Clin. Lab. Investig. Suppl."},{"issue":"3","key":"10.1016\/j.intimp.2025.114427_bb0180","first-page":"191","article-title":"Possible anti-inflammatory effects of mesenchymal stem cells transplantation via changes in CXCL8 levels in patients with refractory rheumatoid arthritis","volume":"8","author":"Gowhari Shabgah","year":"2019","journal-title":"Int. J. Mol. Cell Med."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0185","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/etm.2021.9890","article-title":"microRNA-23 inhibits inflammation to alleviate rheumatoid arthritis via regulating CXCL12","volume":"21","author":"Gao","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2025.114427_bb0190","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/annrheumdis-2020-eular.3761","article-title":"FRI0105 evaluation of CXCL13 and ICAM1 serum levels as predictors of clinical response to Abatacept in rheumatoid arthritis","volume":"79","author":"Piantoni","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2025.114427_bb0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mod.2018.05.006","article-title":"Fos metamorphoses: lessons from mutants in model organisms","volume":"154","author":"Alfonso-Gonzalez","year":"2018","journal-title":"Mech. Dev."},{"issue":"7","key":"10.1016\/j.intimp.2025.114427_bb0200","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/1529-0131(199907)42:7<1517::AID-ANR27>3.0.CO;2-G","article-title":"Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis","volume":"42","author":"Westhoff","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0205","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s10753-021-01459-2","article-title":"MLL3 inhibits apoptosis of rheumatoid arthritis fibroblast-like synoviocytes and promotes secretion of inflammatory factors by activating CCL2 and the NF-\u03baB pathway","volume":"44","author":"Fan","year":"2021","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2025.114427_bb0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41419-024-06570-4","article-title":"CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA","volume":"15","author":"Tang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.114427_bb0215","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.16643","article-title":"Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma","volume":"11","author":"Wei","year":"2023","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.intimp.2025.114427_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010297","article-title":"A novel role of BIRC3 in Stemness reprogramming of glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.114427_bb0225","article-title":"Integrated analysis to obtain potential prognostic signature in glioblastoma","volume":"15","author":"Chen","year":"2021","journal-title":"Front. Integr. Neurosci."},{"issue":"5","key":"10.1016\/j.intimp.2025.114427_bb0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.21873\/cgp.20344","article-title":"Prognostic significance of the BIRC2-BIRC3 gene signature in head and neck squamous cell carcinoma","volume":"19","author":"Lee","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"6","key":"10.1016\/j.intimp.2025.114427_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286783","article-title":"Differential regulation of BIRC2 and BIRC3 expression by inflammatory cytokines and glucocorticoids in pulmonary epithelial cells","volume":"18","author":"Thorne","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2025.114427_bb0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.fsi.2022.04.012","article-title":"Inhibition of lysozyme lytic activity by ivy derived from Photobacterium damselae subsp. piscicida","volume":"124","author":"Nishihara","year":"2022","journal-title":"Fish Shellfish Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.114427_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006448","article-title":"Structure of the Neisseria Adhesin complex protein (ACP) and its role as a novel lysozyme inhibitor","volume":"13","author":"Humbert","year":"2017","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.intimp.2025.114427_bb0250","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1158\/1078-0432.CCR-12-2518","article-title":"The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells","volume":"19","author":"Krepler","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114427_bb0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41598-021-04042-9","article-title":"BIRC2-BIRC3 amplification: a potentially druggable feature of a subset of head and neck cancers in patients with Fanconi anemia","volume":"12","author":"Roohollahi","year":"2022","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.intimp.2025.114427_bb0260","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/ard-2022-222871","article-title":"Stage-specific roles of microbial dysbiosis and metabolic disorders in rheumatoid arthritis","volume":"81","author":"Cheng","year":"2022","journal-title":"Ann. Rheum. Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:07:15Z","timestamp":1757912835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":52,"alternative-id":["S1567576925004175"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114427","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysozyme modulates inflammatory responses to exacerbate the severity of rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114427"}}